DUBLIN--(BUSINESS WIRE)--
ICON plc, (NASDAQ: ICLR),
today announced the successful completion and settlement of the private
placement by its subsidiary ICON Investment Five Unlimited Company (the
"Issuer") of $350,000,000 aggregate principal amount of its 3.64% Senior
Notes due 2020 (the "Notes"). The Notes will mature on December 15,
2020. Interest is payable semi-annually on the Notes on each June 15 and
December 15, commencing June 15, 2016. The Notes are guaranteed by ICON
plc.
The Notes may be redeemed, at the Issuer's option, at any time prior to
maturity, at par plus a make whole premium, together with accrued and
unpaid interest, if any, to the redemption date.
The terms of the notes are set forth in the Note Purchase Agreement,
dated as of December 15, 2015, by and among the Issuer, ICON plc and the
purchasers named therein.
The Issuer expects to use the proceeds from the sale of the Notes to
refinance certain existing debt facilities.
The Notes have not been, and will not be, registered under the
Securities Act of 1933, as amended, and may not be offered or sold in
the United States absent registration or an applicable exemption from
registration requirements. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy any security.
About ICON plc
ICON plc is a global provider of drug development solutions and services
to the pharmaceutical, biotechnology and medical device industries. The
company specialises in the strategic development, management and
analysis of programs that support clinical development - from compound
selection to Phase I-IV clinical studies. With headquarters in Dublin,
Ireland, ICON currently, operates from 89 locations in 38 countries and
has approximately 11,900 employees.
Further information is available at www.iconplc.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and industry
conditions. These statements are not guarantees of future performance or
actual results, and actual results, developments and business decisions
may differ from those stated in this press release. The forward-looking
statements are subject to future events, risks, uncertainties and other
factors that could cause actual results to differ materially from those
projected in the statements, including, but not limited to, the ability
to enter into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the integration of
new business mergers and acquisitions, as well as economic and global
market conditions and other risks and uncertainties detailed from time
to time in SEC reports filed by ICON, all of which are difficult to
predict and some of which are beyond our control. For these reasons, you
should not place undue reliance on these forward-looking statements when
making investment decisions. The word "expected" and variations of such
words and similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they are
made and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information, future
events or otherwise. More information about the risks and uncertainties
relating to these forward-looking statements may be found in SEC reports
filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are
available on the SEC's website at http://www.sec.gov.
ICON/ICLR-F
View source version on businesswire.com: http://www.businesswire.com/news/home/20151216005456/en/
ICON plc
Investor Relations, 1-888-381-7923
or
Brendan
Brennan, + 353 -1-291-2000
Chief Financial Officer
or
Simon
Holmes, + 353 -1-291-2000
EVP Investor Relations and Corporate
Development
Source: ICON plc
News Provided by Acquire Media
